Oncoinvent ASA, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, announced that it has entered into an agreement...
Maze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal,...
Ionpath, a leader in high-definition spatial proteomics, announced the launch of MIBIslide Blue, a groundbreaking advancement in multimodal imaging. Featuring a proprietary optically transparent...
Ipsen and Biomunex Pharmaceuticals announced an exclusive global licensing agreement for BMX-502. BMX-502 is a bispecific antibody that engages and activates a subset of...
Smart Immune, a clinical-stage biotechnology company, and CELLforCURE by SEQENS, a Contract Development and Manufacturing Organization (CDMO) for Advanced Therapy Medical Products (ATMPs), announced...
